Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Qiagen N.V. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 279
- −1 vs. Q2 2023
- Shares held
- 133.7M
- −2.75M (−2.0%) vs. Q2 2023
- Total value
- $5.40B
- −$733.6M (−12.0%) vs. Q2 2023
- New holders
- 30
- 101 more added
- Sold out
- 31
- 105 more reduced
3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $5.68B |
| Q1 2026 | 346 | $5.02B |
| Q4 2025 | 322 | $6.77B |
| Q3 2025 | 339 | $6.84B |
| Q2 2025 | 318 | $7.23B |
| Q1 2025 | 300 | $5.92B |
| Q4 2024 | 325 | $6.60B |
| Q3 2024 | 330 | $7.05B |
| Q2 2024 | 305 | $6.22B |
| Q1 2024 | 282 | $5.83B |
| Q4 2023 | 278 | $6.09B |
| Q3 2023 | 279 | $5.40B |
| Q2 2023 | 283 | $6.14B |
| Q1 2023 | 288 | $6.23B |
| Q4 2022 | 300 | $6.76B |
| Q3 2022 | 297 | $5.73B |
| Q2 2022 | 289 | $6.11B |
| Q1 2022 | 294 | $6.39B |
| Q4 2021 | 302 | $7.40B |
| Q3 2021 | 267 | $6.77B |
| Q2 2021 | 259 | $5.98B |
| Q1 2021 | 276 | $5.97B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Qiagen N.V.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Central Trust Co | 0 | $0 | 0.00% | −460−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Lapides Asset Management, LLC | – | – | – | – | Not filed |
| First Capital Advisors Group, LLC. | – | – | – | – | Not filed |